A consensus redefinition of transfusion-related acute lung injury.
Journal
Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
07
01
2019
revised:
16
03
2019
accepted:
18
03
2019
pubmed:
18
4
2019
medline:
28
5
2020
entrez:
18
4
2019
Statut:
ppublish
Résumé
Transfusion-related acute lung injury (TRALI) is a serious complication of blood transfusion and is among the leading causes of transfusion-related morbidity and mortality in most developed countries. In the past decade, the pathophysiology of this potentially life-threatening syndrome has been increasingly elucidated, large cohort studies have identified associated patient conditions and transfusion risk factors, and preventive strategies have been successfully implemented. These new insights provide a rationale for updating the 2004 consensus definition of TRALI. An international expert panel used the Delphi methodology to develop a redefinition of TRALI by modifying and updating the 2004 definition. Additionally, the panel reviewed issues related to TRALI nomenclature, patient conditions associated with acute respiratory distress syndrome (ARDS) and TRALI, TRALI pathophysiology, and standardization of reporting of TRALI cases. In the redefinition, the term "possible TRALI" has been dropped. The terminology of TRALI Type I (without an ARDS risk factor) and TRALI Type II (with an ARDS risk factor or with mild existing ARDS) is proposed. Cases with an ARDS risk factor that meet ARDS diagnostic criteria and where respiratory deterioration over the 12 hours before transfusion implicates the risk factor as causative should be classified as ARDS. TRALI remains a clinical diagnosis and does not require detection of cognate white blood cell antibodies. Clinicians should report all cases of posttransfusion pulmonary edema to the transfusion service so that further investigation can allow for classification of such cases as TRALI (Type I or Type II), ARDS, transfusion-associated circulatory overload (TACO), or TRALI or TACO cannot distinguish or an alternate diagnosis.
Sections du résumé
BACKGROUND
Transfusion-related acute lung injury (TRALI) is a serious complication of blood transfusion and is among the leading causes of transfusion-related morbidity and mortality in most developed countries. In the past decade, the pathophysiology of this potentially life-threatening syndrome has been increasingly elucidated, large cohort studies have identified associated patient conditions and transfusion risk factors, and preventive strategies have been successfully implemented. These new insights provide a rationale for updating the 2004 consensus definition of TRALI.
STUDY DESIGN AND METHODS
An international expert panel used the Delphi methodology to develop a redefinition of TRALI by modifying and updating the 2004 definition. Additionally, the panel reviewed issues related to TRALI nomenclature, patient conditions associated with acute respiratory distress syndrome (ARDS) and TRALI, TRALI pathophysiology, and standardization of reporting of TRALI cases.
RESULTS
In the redefinition, the term "possible TRALI" has been dropped. The terminology of TRALI Type I (without an ARDS risk factor) and TRALI Type II (with an ARDS risk factor or with mild existing ARDS) is proposed. Cases with an ARDS risk factor that meet ARDS diagnostic criteria and where respiratory deterioration over the 12 hours before transfusion implicates the risk factor as causative should be classified as ARDS. TRALI remains a clinical diagnosis and does not require detection of cognate white blood cell antibodies.
CONCLUSIONS
Clinicians should report all cases of posttransfusion pulmonary edema to the transfusion service so that further investigation can allow for classification of such cases as TRALI (Type I or Type II), ARDS, transfusion-associated circulatory overload (TACO), or TRALI or TACO cannot distinguish or an alternate diagnosis.
Identifiants
pubmed: 30993745
doi: 10.1111/trf.15311
pmc: PMC6850655
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2465-2476Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL138673
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2019 The Authors. Transfusion published by Wiley Periodicals, Inc. on behalf of AABB.
Références
Ann Am Thorac Soc. 2015 Sep;12(9):1328-35
pubmed: 26102516
Blood. 2006 Feb 1;107(3):1217-9
pubmed: 16210340
J Clin Invest. 2009 Nov;119(11):3450-61
pubmed: 19809160
Transfusion. 2006 Sep;46(9):1465-8
pubmed: 16965569
Arthroscopy. 2018 Feb;34(2):349-351
pubmed: 29413182
Crit Care Med. 2010 Mar;38(3):771-8
pubmed: 20035217
Transfus Med. 1998 Mar;8(1):49-56
pubmed: 9569460
N Engl J Med. 2000 May 4;342(18):1301-8
pubmed: 10793162
N Engl J Med. 2006 Jun 15;354(24):2564-75
pubmed: 16714767
Transfusion. 2017 Mar;57(3):709-713
pubmed: 28019007
Blood. 2011 Jan 13;117(2):669-77
pubmed: 21030555
Transfusion. 2015 May;55(5):947-52
pubmed: 25488517
Crit Care Med. 2012 Aug;40(8):2488-91
pubmed: 22809916
Liver Transpl. 2011 Feb;17(2):149-58
pubmed: 21280188
Crit Care. 2009;13(1):R1
pubmed: 19152704
Transfusion. 2016 Sep;56(9):2395-7
pubmed: 27624213
Crit Care Med. 2005 Apr;33(4):721-6
pubmed: 15818095
Am J Respir Crit Care Med. 2007 Nov 1;176(9):886-91
pubmed: 17626910
Transfusion. 2009 Nov;49(11):2434-41
pubmed: 19624605
Crit Care Med. 2008 Dec;36(12):3283-4; author reply 3284
pubmed: 19020453
Vox Sang. 1957 Sep;2(4):242-8
pubmed: 13496693
Lancet. 2016 Dec 3;388(10061):2825-2836
pubmed: 27083327
Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):293-301
pubmed: 7842182
J Clin Invest. 2006 Jun;116(6):1615-23
pubmed: 16710475
J Clin Invest. 1998 Apr 1;101(7):1458-67
pubmed: 9525989
Transfusion. 2001 Mar;41(3):317-22
pubmed: 11274583
Transfusion. 2006 Sep;46(9):1478-83
pubmed: 16965572
Intensive Care Med. 2010 Oct;36(10):1710-7
pubmed: 20658125
Crit Care. 2011;15(1):R59
pubmed: 21314930
Transfusion. 2011 Oct;51(10):2078-91
pubmed: 21446938
Lancet. 2013 Sep 14;382(9896):984-94
pubmed: 23642914
Transfusion. 2010 Nov;50(11):2447-54
pubmed: 20529001
Vox Sang. 2009 Apr;96(3):266-9
pubmed: 19207164
Vox Sang. 2008 Nov;95(4):313-7
pubmed: 19138261
Vox Sang. 2012 May;102(4):317-23
pubmed: 21967322
Transfusion. 2009 Jan;49(1):13-20
pubmed: 18954397
Transfusion. 2008 Mar;48(3):541-5
pubmed: 18067496
Blood. 2009 Feb 26;113(9):2079-87
pubmed: 19131548
Blood. 2011 Apr 21;117(16):4218-25
pubmed: 21325598
Blood. 2003 Jan 15;101(2):454-62
pubmed: 12393667
Transfusion. 2003 May;43(5):633-40
pubmed: 12702186
Crit Care Med. 2006 May;34(5 Suppl):S124-31
pubmed: 16617256
Anesthesiology. 2010 Jul;113(1):92-103
pubmed: 20508493
Intensive Care Med. 2012 Oct;38(10):1573-82
pubmed: 22926653
Crit Care Med. 2008 Jun;36(6):1796-802
pubmed: 18496377
Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):818-24
pubmed: 7509706
Transfusion. 2015 Jan;55(1):164-75
pubmed: 25135630
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Blood. 2012 Feb 16;119(7):1757-67
pubmed: 22117051
Transfusion. 2011 Jun;51(6):1278-83
pubmed: 21133929
J Clin Invest. 2012 Jul;122(7):2661-71
pubmed: 22684106
Anesthesiology. 2008 Jan;108(1):46-54
pubmed: 18156881
Crit Care Res Pract. 2012;2012:720950
pubmed: 22701787
Ann Intern Med. 1970 Nov;73(5):689-94
pubmed: 5312202
Transfusion. 2001 Oct;41(10):1244-8
pubmed: 11606823
Transfusion. 2005 Jul;45(7):1056-63
pubmed: 15987348
Am J Physiol Cell Physiol. 2002 Dec;283(6):C1592-603
pubmed: 12388071
Curr Pharm Des. 2012;18(22):3260-6
pubmed: 22621270
Br J Haematol. 2002 Mar;116(3):673-6
pubmed: 11849232
Blood. 2010 Aug 26;116(8):1360-8
pubmed: 20479286
Intensive Care Med. 2010 May;36(5):879-87
pubmed: 20221752
Transfusion. 2017 Oct;57(10):2539-2541
pubmed: 28691321
Transfusion. 2019 Feb;59(2):795-805
pubmed: 30488959
Transfusion. 2016 Sep;56(9):2384-8
pubmed: 27184913
Transfusion. 2010 Feb;50(2):443-51
pubmed: 19804567
Transfus Med. 2017 Dec;27(6):393-400
pubmed: 29282809
Transfusion. 1985 Nov-Dec;25(6):573-7
pubmed: 4071603
J Cardiol. 2016 Feb;67(2):192-8
pubmed: 26116209
Lancet Haematol. 2019 Jul;6(7):e350-e358
pubmed: 31080132
Transfus Med Rev. 2018 Jan;32(1):16-27
pubmed: 28864336
Blood Transfus. 2018 May;16(3):227-234
pubmed: 28488955
Transfusion. 2015 May;55(5):1128-34
pubmed: 25647304
Br J Haematol. 2007 Mar;136(6):788-99
pubmed: 17341264
Transfusion. 2004 Dec;44(12):1774-89
pubmed: 15584994
Med Sci Monit. 2010 Oct;16(10):CS129-34
pubmed: 20885357
Lancet. 1998 Nov 14;352(9140):1601-2
pubmed: 9843115